News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Substance Use Disorder

Latest News

schizophrenia

May 18th 2026

Premature Mortality in Schizophrenia: What Clinicians Can Do

By Faith Dickerson, PhD, MPH

Why schizophrenia shortens life: smoking, metabolic risks, and care gaps drive a 15-year mortality loss—and clinicians can help close it.

Sophia/Adobe Stock

GLP-1s For Treatment of Alcohol Use Disorder: Current and Future Directions

By Jessica Walters

Using Neuromelanin-Sensitive MRI to Examine Catecholaminergic Disorders Over Time

By Marieke van der Pluijm, PhD, Jessica Walters

substance use disorder

April 20th 2026

Empathetic Curiosity: Better Engaging Youth With Substance Use Disorder

By Leah Kuntz, Stephen Mateka, DO

CME Content

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Monoamines: A Full House

Dose Lithium Once a Day at Night: An Update

Addressing Sexual Wellness: A Psychiatric Perspective

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia